2009-11-03 - SwedenBIO
The event, hosted by Swedish EPP MEP Christofer Fjellner, highlighted the increasingly influential role played by patients in managing their own care and recovery.
So far, more than 350 million patients have benefitted from medicines manufactured through biotechnology and gene technology.